This site is intended for healthcare professionals only

Paediatric DSNs improve glycaemic control in children with type 1 diabetes

John Harvey

The goal of attaining good glycaemic control in children with diabetes remains very challenging despite the availability of new insulins, more sophisticated devices and better models of care.

Data from the Epidemiology of Diabetes Interventions and Complications study demonstrated the importance of good glycaemic control in the early years of type 1 diabetes to achieve a reduced risk of complications, increased longevity and a quality of life comparable to people without diabetes (Nathan et al, 2005).

A recent analysis by the Brecon Group (Box 1) looked at changes in glycaemic control in Welsh children with type 1 diabetes from 2001 to 2006 (O’Hagan et al, 2010). A modest improvement was seen, with a reduction in mean HbA1c across Wales from 9.1% to 8.9% (76−74 mmol/mol).

Of the 12 contributing centres, five had appointed a full-time paediatric DSN, having not had one previously. These paediatric clinics had previously relied on support from adult DSNs who had to fit children in among their busy adult clinic commitments. It was the centres with new paediatric DSNs that showed greatest improvement in glycaemic control; in these centres, mean HbA1c reduced from 9.6% to 8.7% (81−72 mmol/mol).

Glycaemic control was generally worse in older children, and greater insulin dose was associated with poorer glycaemic control. The implication, therefore, is that more insulin gets prescribed for worse glycaemic control in adolescents who are probably not taking their prescribed regimen in full.

When the influence of the new paediatric DSNs on the different age groups were compared, it was the older children (aged over 10 years) who showed the greatest improvement, with little change in the younger people. This improvement occurred with no increase in prescribed insulin dose.

Since the DSNs produced better control without more insulin we believe that they generated better adherence in the adolescent population. They achieved this through greater contact with the young people. There were more home and school visits and nurse clinic sessions were established between doctor appointments (O’Hagan et al, 2010).

In other studies, paediatric DSNs have been shown to improve clinic attendance rates and reduce length of stay (Cowan et al, 1997), but there has been little previously published data on their effects on glycaemic control.

In the continuing quest to obtain the specialist nurse staffing that optimum care requires, it is useful to obtain more data to demonstrate the benefits that can be gained, and important to show their impact on the issue of diabetes care in adolescence.

The goal of attaining good glycaemic control in children with diabetes remains very challenging despite the availability of new insulins, more sophisticated devices and better models of care.

Data from the Epidemiology of Diabetes Interventions and Complications study demonstrated the importance of good glycaemic control in the early years of type 1 diabetes to achieve a reduced risk of complications, increased longevity and a quality of life comparable to people without diabetes (Nathan et al, 2005).

A recent analysis by the Brecon Group (Box 1) looked at changes in glycaemic control in Welsh children with type 1 diabetes from 2001 to 2006 (O’Hagan et al, 2010). A modest improvement was seen, with a reduction in mean HbA1c across Wales from 9.1% to 8.9% (76−74 mmol/mol).

Of the 12 contributing centres, five had appointed a full-time paediatric DSN, having not had one previously. These paediatric clinics had previously relied on support from adult DSNs who had to fit children in among their busy adult clinic commitments. It was the centres with new paediatric DSNs that showed greatest improvement in glycaemic control; in these centres, mean HbA1c reduced from 9.6% to 8.7% (81−72 mmol/mol).

Glycaemic control was generally worse in older children, and greater insulin dose was associated with poorer glycaemic control. The implication, therefore, is that more insulin gets prescribed for worse glycaemic control in adolescents who are probably not taking their prescribed regimen in full.

When the influence of the new paediatric DSNs on the different age groups were compared, it was the older children (aged over 10 years) who showed the greatest improvement, with little change in the younger people. This improvement occurred with no increase in prescribed insulin dose.

Since the DSNs produced better control without more insulin we believe that they generated better adherence in the adolescent population. They achieved this through greater contact with the young people. There were more home and school visits and nurse clinic sessions were established between doctor appointments (O’Hagan et al, 2010).

In other studies, paediatric DSNs have been shown to improve clinic attendance rates and reduce length of stay (Cowan et al, 1997), but there has been little previously published data on their effects on glycaemic control.

In the continuing quest to obtain the specialist nurse staffing that optimum care requires, it is useful to obtain more data to demonstrate the benefits that can be gained, and important to show their impact on the issue of diabetes care in adolescence.

REFERENCES:

Cowan FJ, Warner JT, Lowes LM et al (1997) Auditing paediatric diabetes care and the impact of a specialist nurse trained in paediatric diabetes. Arch Dis Child 77: 109−14
Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 22: 2643−53
O’Hagan M, Harvey JN on behalf of the Brecon Group (2010) Glycaemic control in children with type 1 diabetes in Wales: the influence of the Paediatric Diabetes Specialist Nurse. Diabetes Care April 27 [Epub ahead of print]

Related content
Another year over – and here’s what we’ve done!
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.